JP2015520197A5 - - Google Patents

Download PDF

Info

Publication number
JP2015520197A5
JP2015520197A5 JP2015517568A JP2015517568A JP2015520197A5 JP 2015520197 A5 JP2015520197 A5 JP 2015520197A5 JP 2015517568 A JP2015517568 A JP 2015517568A JP 2015517568 A JP2015517568 A JP 2015517568A JP 2015520197 A5 JP2015520197 A5 JP 2015520197A5
Authority
JP
Japan
Prior art keywords
less
composition according
hydrophobic
targeting moiety
hydrophilic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015517568A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015520197A (ja
JP6275707B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2013/050475 external-priority patent/WO2013188979A1/en
Publication of JP2015520197A publication Critical patent/JP2015520197A/ja
Publication of JP2015520197A5 publication Critical patent/JP2015520197A5/ja
Application granted granted Critical
Publication of JP6275707B2 publication Critical patent/JP6275707B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015517568A 2012-06-20 2013-06-20 粘膜付着性ナノ粒子送達系 Active JP6275707B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261690127P 2012-06-20 2012-06-20
US61/690,127 2012-06-20
PCT/CA2013/050475 WO2013188979A1 (en) 2012-06-20 2013-06-20 Mucoadhesive nanoparticle delivery system

Publications (3)

Publication Number Publication Date
JP2015520197A JP2015520197A (ja) 2015-07-16
JP2015520197A5 true JP2015520197A5 (cg-RX-API-DMAC7.html) 2016-09-15
JP6275707B2 JP6275707B2 (ja) 2018-02-07

Family

ID=49767986

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015517568A Active JP6275707B2 (ja) 2012-06-20 2013-06-20 粘膜付着性ナノ粒子送達系

Country Status (8)

Country Link
US (2) US20140005379A1 (cg-RX-API-DMAC7.html)
EP (1) EP2863892B1 (cg-RX-API-DMAC7.html)
JP (1) JP6275707B2 (cg-RX-API-DMAC7.html)
KR (1) KR102177557B1 (cg-RX-API-DMAC7.html)
CN (1) CN104507458B (cg-RX-API-DMAC7.html)
CA (1) CA2877051C (cg-RX-API-DMAC7.html)
ES (1) ES2658972T3 (cg-RX-API-DMAC7.html)
WO (1) WO2013188979A1 (cg-RX-API-DMAC7.html)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012019168A2 (en) 2010-08-06 2012-02-09 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
ES3005233T3 (en) 2010-10-01 2025-03-14 Modernatx Inc Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
DE12722942T1 (de) 2011-03-31 2021-09-30 Modernatx, Inc. Freisetzung und formulierung von manipulierten nukleinsäuren
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
RU2648950C2 (ru) 2011-10-03 2018-04-02 Модерна Терапьютикс, Инк. Модифицированные нуклеозиды, нуклеотиды и нуклеиновые кислоты и их применение
AU2012352180A1 (en) 2011-12-16 2014-07-31 Moderna Therapeutics, Inc. Modified nucleoside, nucleotide, and nucleic acid compositions
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
US9254311B2 (en) 2012-04-02 2016-02-09 Moderna Therapeutics, Inc. Modified polynucleotides for the production of proteins
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
WO2013151663A1 (en) 2012-04-02 2013-10-10 modeRNA Therapeutics Modified polynucleotides for the production of membrane proteins
US20140005379A1 (en) 2012-06-20 2014-01-02 Frank GU Nanoparticle delivery system and components thereof
US9878000B2 (en) 2012-06-20 2018-01-30 University Of Waterloo Mucoadhesive nanoparticle composition comprising immunosuppresant and methods of use thereof
HRP20220607T1 (hr) 2012-11-26 2022-06-24 Modernatx, Inc. Terminalno modificirana rna
US9757529B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
EP2971010B1 (en) 2013-03-14 2020-06-10 ModernaTX, Inc. Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
JP2016518388A (ja) 2013-04-30 2016-06-23 オティトピック インク. 乾燥粉末配合および使用方法
AU2014321215B2 (en) 2013-09-23 2020-07-16 Rensselaer Polytechnic Institute Nanoparticle-mediated gene delivery, genomic editing and ligand-targeted modification in various cell populations
EP3052106A4 (en) 2013-09-30 2017-07-19 ModernaTX, Inc. Polynucleotides encoding immune modulating polypeptides
KR20160067219A (ko) 2013-10-03 2016-06-13 모더나 세라퓨틱스, 인코포레이티드 저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드
WO2016007647A1 (en) * 2014-07-09 2016-01-14 The Johns Hopkins University Glutaminase inhibitor discovery and nanoparticle-enhanced delivery for cancer therapy
DE102014012675A1 (de) * 2014-08-26 2016-03-03 Wavelight Gmbh Vernetzung von Augengewebe
JP2017538796A (ja) * 2014-10-09 2017-12-28 ディストレット テクノロジーコ シシリア ミクロ エ ナノ システミ エス.シー.エー.アール.エル. 両親媒性共重合体、それらの調製および薬物の送達のための使用
WO2016176768A1 (en) * 2015-05-04 2016-11-10 University Of Waterloo Mucoadhesive nanoparticle composition comprising immunosuppresant and methods of use thereof
WO2017019792A1 (en) * 2015-07-27 2017-02-02 The Texas A&M University System Surface active nanosystems
WO2017019773A1 (en) * 2015-07-28 2017-02-02 Layerbio, Inc. Sustained-release drug formulations for glaucoma
CA2996910C (en) * 2015-09-01 2023-08-22 Mcmaster University Micelles for mucoadhesive drug delivery
US10765745B2 (en) * 2015-09-09 2020-09-08 Board Of Regents, The University Of Texas System Multifunctional nanoparticle systems and methods for cancer diagnosis and combination therapy
US10987434B2 (en) * 2015-10-21 2021-04-27 The Regents Of The University Of Michigan Detection and treatment of caries and microcavities with nanoparticles
KR101721977B1 (ko) * 2015-11-02 2017-03-31 영남대학교 산학협력단 약물 지속 방출형 나노 입자 및 상기 나노입자로 표면개질된 췌장소도세포를 포함하는 당뇨병 치료용 약학 조성물
CN106680248B (zh) * 2015-11-05 2019-03-05 南京理工大学 基于金丝桃素与1-芘丁酸作用的dna荧光分析方法
EP3409772B1 (en) 2016-01-29 2023-06-28 National University Corporation Hokkaido University Intracellular substance transport system and use thereof
JP6703408B2 (ja) * 2016-01-30 2020-06-03 国立大学法人 筑波大学 ポリイオンコンプレックスを有効成分とするドライアイ処置用組成物
WO2017204475A1 (ko) * 2016-05-24 2017-11-30 한양대학교 산학협력단 항암제 함유 나노입자를 포함하는 뇌질환 치료를 위한 비강 투여용 약제학적 조성물
WO2018045199A2 (en) * 2016-08-31 2018-03-08 Kansas State University Research Foundation Nucleic acid-peptide capsule complexes
CN106265594B (zh) * 2016-09-21 2019-07-26 南京医科大学 一种缺血性脑卒中靶向的红细胞膜仿生智能药物载体及其制备方法
US10427194B2 (en) 2016-09-28 2019-10-01 Arizona Board Of Regents On Behalf Of Arizona State University Microwave-enabled thermal remediation of organic chemical contaminated soils using dielectric nanomaterials as additives
KR102002612B1 (ko) * 2016-10-25 2019-07-22 서강대학교 산학협력단 녹내장 치료용 안약 제제
CN106581691B (zh) * 2016-12-04 2019-09-10 苏州大学 还原响应的靶向聚乙二醇-聚碳酸酯美登素前药胶束、其制备方法与应用
KR20240172763A (ko) 2016-12-14 2024-12-10 리간달 인코포레이티드 핵산 및/또는 단백질 적재물 전달을 위한 조성물 및 방법
US11021529B2 (en) 2017-03-03 2021-06-01 Massachusetts Institute Of Technology Antimicrobial constructs and uses thereof
JPWO2019004482A1 (ja) * 2017-06-26 2020-08-13 国立大学法人 東京大学 複素環式ボロン酸誘導体
BR102017016440A2 (pt) 2017-07-31 2019-03-19 Universidade Federal Do Rio Grande Do Sul Composição para terapia gênica do sistema nervoso central, processo de obtenção e uso da mesma
US10786456B2 (en) 2017-09-22 2020-09-29 Otitopic Inc. Inhaled aspirin and magnesium to treat inflammation
AU2017432640B2 (en) 2017-09-22 2023-11-30 Aspeya US Inc. Dry powder compositions with magnesium stearate
CN107569454B (zh) * 2017-09-29 2018-05-04 深圳大佛药业股份有限公司 一种盐酸奥洛他定鼻喷雾剂及其制备方法
ES2711669A1 (es) * 2017-11-02 2019-05-06 Univ Santiago Compostela Sistemas de liberacion de farmacos de acido polisialico y metodos
WO2019126739A1 (en) 2017-12-21 2019-06-27 Shepherd Therapeutics, Inc. Pyrvinium pamoate anti-cancer therapies
CN108251409B (zh) * 2018-01-11 2020-02-11 山东交通学院 一种吸附降解油污的复合微生物导弹材料及其制备方法
US10590020B2 (en) 2018-01-18 2020-03-17 Arizona Board Of Regents On Behalf Of Arizona State University Additive-amplified microwave pretreatment of wastewater sludge
CN108451895A (zh) * 2018-04-26 2018-08-28 霍尔果斯汉智医药科技有限公司 一种左炔诺孕酮阴道膨胀栓及其制备方法
US20210299218A1 (en) * 2018-08-01 2021-09-30 Nanoneuron Therapeutics, Inc. Neuroprotective compositions and use thereof
JP7164700B2 (ja) 2018-09-11 2022-11-01 リードバイオセラピューティクスリミテッド 粘膜付着性分散ナノ粒子系およびその製造方法
US20210113715A1 (en) * 2018-09-14 2021-04-22 Cedars-Sinai Medical Center Targeted nanoparticles for diagnosing, detecting and treating cancer
US11000482B2 (en) * 2018-11-21 2021-05-11 University Of South Carolina Fabrication of a suramin-loaded nanoparticle and its application
US11458092B2 (en) 2018-12-14 2022-10-04 NuVessl, Inc. Composition with enhanced passenger molecule loading
CN110075345B (zh) * 2019-04-01 2021-12-10 杭州英健生物科技有限公司 适用于胃窥镜喷涂到胃损伤黏膜表面的双组分自粘性胃黏膜保护胶及其应用
CN109875964B (zh) * 2019-03-27 2021-08-27 内江西凯杰成医药科技有限公司 一种阿霉素无载体纳米药物的制备及其应用
WO2020210378A1 (en) * 2019-04-08 2020-10-15 University Of Massachusetts Localization of payload delivery systems to tumor sites via beacon cell targeting
CN111848835B (zh) * 2019-04-30 2023-02-03 苏州大学 含氟化合物修饰的壳聚糖在透皮给药制剂制备中的应用
CN110200941B (zh) * 2019-06-24 2020-05-15 苏州大学 作用于小肠的辐射防护纳米药物及其制备方法
CN112274646B (zh) * 2019-07-12 2023-06-02 北京茵诺医药科技有限公司 用于靶向活化cd44分子的双亲性蛋白质-高分子结合体递送系统、其制备方法和应用
US20220339117A1 (en) 2019-09-04 2022-10-27 The Trustees Of Princeton University Comb polymer and block copolymer stabilized nanoparticles encapsulating nucleic acids and other soluble hydrophilic compounds
CN110755597B (zh) * 2019-10-24 2023-07-07 广州市希丽生物科技服务有限公司 用于预防和治疗类风湿性关节炎的外用药物组合物
CN111620924A (zh) * 2020-06-04 2020-09-04 华中农业大学 基于天然产物的药物设计方法、五环三萜类化合物、其制备方法及应用
WO2022006685A1 (en) * 2020-07-10 2022-01-13 Nuecology Biomedical Inc. Injectable high-drug-loaded nanocomposite gels and process for making the same
CN112206325B (zh) * 2020-09-21 2022-11-18 温州医科大学附属眼视光医院 一种长眼表滞留人工泪液及其制备方法
US20240033219A1 (en) * 2020-12-09 2024-02-01 The Regents Of The University Of California Compositions and methods for mucosal drug delivery
CN112783163A (zh) * 2020-12-29 2021-05-11 江西方迪科技有限公司 密集架的智能记忆控制系统
CN112691087B (zh) * 2021-01-25 2022-02-25 潍坊医学院 一种那他霉素纳米粒及其制备方法
CN113077942B (zh) * 2021-04-12 2021-12-17 西北工业大学 一种基于功率超声制备智能柔性导电薄膜及其应用
WO2022246175A1 (en) * 2021-05-21 2022-11-24 The Trustees Of Columbia University In The City Of New York Compositions and methods for treating depression and anxiety
CN113876716B (zh) * 2021-10-14 2023-03-10 中山大学·深圳 一种治疗胃肠道疾病的生物粘附性纳米粒及其制备方法
US20240335575A1 (en) * 2021-10-20 2024-10-10 Aphios Corporation Method and apparatus for inactivating pathogens in units of whole blood using superparamagnetic nanoparticles coated with chemiluminescence reagents and broad-spectrum anti-viral therapeutics
WO2023092208A1 (pt) * 2021-11-25 2023-06-01 Universidade Estadual De Campinas Processo de obtenção de solução polimérica injetável fotoreticulável, solução polimérica injetável fotoreticulável e seus usos
EP4447951A2 (en) * 2021-12-16 2024-10-23 Alveolus Bio, Inc. Inhalable or ingestible lactic acid compositions for the treatment of chronic lung disease
CN119731223A (zh) * 2022-04-29 2025-03-28 佛罗里达大学研究基金会 超高分子量聚合物及其制备和使用方法
CN115558128B (zh) * 2022-09-28 2024-05-24 中国科学院长春应用化学研究所 一种具有过氧化物酶活性水凝胶敷料及其制备方法和应用
AU2023366929A1 (en) 2022-10-25 2025-05-08 Veradermics, Incorporated Compositions and methods of use for modified release minoxidil
US12145890B2 (en) 2022-12-16 2024-11-19 Raytheon Company Coated (core-shell) nanoparticles for nanocomposite optical ceramics
CN115970066B (zh) * 2022-12-29 2024-09-27 成都爱睿康乐医疗器械有限公司 基于主客体相互作用的载药纳米凝胶生物润滑剂及其制备方法和应用
WO2024148431A1 (en) * 2023-01-10 2024-07-18 Nuecology Biomedical Inc. A pharmaceutical composition in the form of an injectable nanocomposite gel for co-delivery of multiple medicines or drugs
WO2024206230A1 (en) * 2023-03-24 2024-10-03 Trustees Of Tufts College Tissue targeting lipids and lipid nanoparticles
CN116617405A (zh) * 2023-04-21 2023-08-22 四川大学 具有粘膜粘附性的脂质体药物载体及其制备方法和应用
CN117562870A (zh) * 2023-11-08 2024-02-20 浙江大学 一种生物相容、装载水不溶性药物的靶向性纳米胶囊及其制备方法

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649047A (en) 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US4839342A (en) 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin
IT1250421B (it) 1991-05-30 1995-04-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
JP3412198B2 (ja) 1993-08-31 2003-06-03 日本油脂株式会社 変性マレイン酸共重合体および用途
US6007845A (en) 1994-07-22 1999-12-28 Massachusetts Institute Of Technology Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
GB9700624D0 (en) 1997-01-14 1997-03-05 Danbiosyst Uk Drug delivery composition
ES2220406T3 (es) 1999-02-19 2004-12-16 Universiteit Utrecht Hidrogeles estereocomplejos.
US6254860B1 (en) 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
US6525145B2 (en) 2000-04-18 2003-02-25 Clemson University Polylactide/dextran graft co-polymers for biomaterial and tissue engineering applications
US7803392B2 (en) 2000-12-27 2010-09-28 University Of Kentucky Research Foundation pH-Sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules
US7354574B2 (en) 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
ES2226567B1 (es) 2003-06-20 2006-07-01 Universidad De Santiago De Compostela Nanoparticulas de acido hialuronico.
US7083802B2 (en) 2003-07-31 2006-08-01 Advanced Ocular Systems Limited Treatment of ocular disease
WO2005055945A2 (en) 2003-12-08 2005-06-23 Gel-Del Technologies, Inc. Mucoadhesive drug delivery devices and methods of making and using thereof
US20090232899A1 (en) 2004-05-21 2009-09-17 David Allan E Mucoadhesive nanocomposite delivery system
US20050281775A1 (en) 2004-06-16 2005-12-22 Carrington Stephen D Mucoadhesive and bioadhesive polymers
US8361439B1 (en) 2005-01-04 2013-01-29 Gp Medical, Inc. Pharmaceutical composition of nanoparticles
US20080145432A1 (en) 2005-03-09 2008-06-19 Yoshinori Kakizawa Fine Particle and Pharmaceutical Preparation
WO2007124132A2 (en) * 2006-04-20 2007-11-01 University Of Utah Research Foundation Polymeric compositions and methods of making and using thereof
EP2019691B1 (en) 2006-05-15 2020-08-12 Massachusetts Institute of Technology Polymers for functional particles
ES2294951B1 (es) 2006-09-28 2008-12-01 Kelian Gutierrez Ugarte Maquina para peinar el cabello en forma de largos mechones de pelo entrelazado en rastas.
US8242165B2 (en) 2006-10-26 2012-08-14 Creighton University Mucoadhesive nanoparticles for cancer treatment
US20090074828A1 (en) 2007-04-04 2009-03-19 Massachusetts Institute Of Technology Poly(amino acid) targeting moieties
EP2167044A1 (en) 2007-06-11 2010-03-31 BioCure, Inc. Mucoadhesive vesicles for drug delivery
WO2009049089A1 (en) * 2007-10-09 2009-04-16 Washington University In St. Louis Ligand directed toroidal nanoparticles for therapy and diagnostic imaging
US8603532B2 (en) 2008-10-20 2013-12-10 Massachusetts Institute Of Technology Nanostructures for drug delivery
US8802075B2 (en) 2009-02-18 2014-08-12 Eyeon Particle Sciences Llc Bi-functional co-polymer use for opthalmic and other topical and local applications
US20110104069A1 (en) 2009-10-30 2011-05-05 The Ohio State University Multi-functional biodegradable particles for selectable targeting, imaging, and therapeutic delivery and use thereof for treating ocular disorders
JP5560719B2 (ja) 2010-01-08 2014-07-30 東レ株式会社 親水性生理活性物質含有微粒子の製造方法
WO2012097049A2 (en) * 2011-01-11 2012-07-19 The University Of North Carolina At Chapel Hill Dna repair enzyme inhibitor nanoparticles and uses thereof
EP2510930A1 (en) 2011-04-15 2012-10-17 Bionanoplus, S.L. Nanoparticles comprising half esters of poly (methyl vinyl ether-co-maleic anhydride) and uses thereof
US9101547B2 (en) 2011-08-04 2015-08-11 Nano And Advanced Materials Institute Limited Enteric-coated capsule containing cationic nanoparticles for oral insulin delivery
US9878000B2 (en) 2012-06-20 2018-01-30 University Of Waterloo Mucoadhesive nanoparticle composition comprising immunosuppresant and methods of use thereof
US20140005379A1 (en) 2012-06-20 2014-01-02 Frank GU Nanoparticle delivery system and components thereof

Similar Documents

Publication Publication Date Title
JP2015520197A5 (cg-RX-API-DMAC7.html)
Jampilek et al. Advances in drug delivery nanosystems using graphene-based materials and carbon nanotubes
George et al. Natural biodegradable polymers based nano-formulations for drug delivery: A review
Kyriakides et al. Biocompatibility of nanomaterials and their immunological properties
Kanwar et al. Green nanotechnology-driven drug delivery assemblies
Xu et al. Smart porous silicon nanoparticles with polymeric coatings for sequential combination therapy
Maurya et al. Strategic use of nanotechnology in drug targeting and its consequences on human health: A focused review
Neerooa et al. Development of polymer-assisted nanoparticles and nanogels for cancer therapy: An update
JP2011519932A5 (cg-RX-API-DMAC7.html)
US20080243113A1 (en) Modification of stent surfaces to impart functionality
Grumezescu Nano-and microscale drug delivery systems: design and fabrication
HK1206270A1 (en) Controlled release formulations for the delivery of hif-1 inhibitors
Michalak et al. Polymeric nanoparticles–a novel solution for delivery of antimicrobial agents
WO2016193810A8 (en) Formation of cyclosporin a/cyclodextrin nanoparticles
Mishra et al. Targeting aspects of nanogels: an overview
RU2018105494A (ru) Улучшенные системы доставки наночастиц
Cui et al. Bacillus-shape design of polymer based drug delivery systems with Janus-faced function for synergistic targeted drug delivery and more effective cancer therapy
JP2018503736A5 (cg-RX-API-DMAC7.html)
Lakkakula et al. Alginate‐Based Nanosystems for Therapeutic Applications
Bahmani et al. Fabrication of poly (ϵ‐caprolactone)/paclitaxel (core)/chitosan/zein/multi‐walled carbon nanotubes/doxorubicin (shell) nanofibers against MCF‐7 breast cancer
Clementino et al. Polysaccharides: New frontiers for nasal administration of medicines
EP3450395A3 (en) Graphene oxide nanoparticle compositions and methods of making the same
Morad et al. Bioengineered metallic nanomaterials for nanoscale drug delivery systems
Mortazavian et al. Preparation, design for optimization and in vitro evaluation of insulin nanoparticles integrating thiolated chitosan derivatives
Pirmoradi et al. Autophagy and biomaterials: a brief overview of the impact of autophagy in biomaterial applications